Volume 373, Issue 1

Search all Cell and Tissue Research articles

July 2018

Parkinson´s disease: Molecules, cells, and circuitries

Issue Editors:

Heiko Braak,
Kelly Del Tredici-Braak,
Thomas Gasser

24 articles in this issue

Special issue “Parkinson’s disease”
Heiko Braak
Kelly Del Tredici-Braak
Thomas Gasser
Editorial 08 June 2018 Pages: 1 - 7
Genetic risk factors in Parkinson’s disease
K. J. Billingsley
S. Bandres-Ciga
A. B. Singleton
Review 13 March 2018 Pages: 9 - 20
The genetic architecture of mitochondrial dysfunction in Parkinson’s disease
S. B. Larsen
Z. Hanss
R. Krüger
Review Open access 25 January 2018 Pages: 21 - 37
The LRRK2 signalling system
Alice Price
Claudia Manzoni
Patrick A. Lewis
Review Open access 08 January 2018 Pages: 39 - 50
Molecular mechanisms of α-synuclein and GBA1 in Parkinson’s disease
Iva Stojkovska
Dimitri Krainc
Joseph R. Mazzulli
Review 24 October 2017 Pages: 51 - 60
iPS cells in the study of PD molecular pathogenesis
Melanie M. Cobb
Abinaya Ravisankar
Steven Finkbeiner
Review 12 December 2017 Pages: 61 - 77
Convergent pathways in Parkinson’s disease
Marta Cherubini
Richard Wade-Martins
Review Open access 23 October 2017 Pages: 79 - 90
Computational systems biology approaches for Parkinson’s disease
Enrico Glaab
Review Open access 29 November 2017 Pages: 91 - 109
Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease
Hana You
Louise-Laure Mariani
Jean-Christophe Corvol
Review 07 March 2018 Pages: 111 - 135
Neurodegeneration and the ordered assembly of α-synuclein
Maria Grazia Spillantini
Michel Goedert
Review Open access 08 November 2017 Pages: 137 - 148
Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity?
Suzanne Chartier
Charles Duyckaerts
Review 05 June 2018 Pages: 149 - 160
The concept of alpha-synuclein as a prion-like protein: ten years after
Jennifer A. Steiner
Emmanuel Quansah
Patrik Brundin
Review 26 February 2018 Pages: 161 - 173
Release and uptake of pathologic alpha-synuclein
Veselin Grozdanov
Karin M. Danzer
Review 06 February 2018 Pages: 175 - 182
In vivo models of alpha-synuclein transmission and propagation
Ariadna Recasens
Ayse Ulusoy
Benjamin Dehay
Review 29 November 2017 Pages: 183 - 193
ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
W. Peelaerts
L. Bousset
R. Melki
Review 27 April 2018 Pages: 195 - 212
A critical review of the prion hypothesis of human synucleinopathies
Gültekin Tamgüney
Amos D. Korczyn
Review 08 November 2017 Pages: 213 - 220
Locus coeruleus
Eduardo E. Benarroch
Review 07 July 2017 Pages: 221 - 232
Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies
María Graciela Cersosimo
Review 01 December 2017 Pages: 233 - 243
The REM sleep circuit and how its impairment leads to REM sleep behavior disorder
Alex Iranzo
Review 30 May 2018 Pages: 245 - 266
Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD?
Satoshi Orimo
Estifanos Ghebremedhin
Ellen Gelpi
Review 04 June 2018 Pages: 267 - 286
Postmortem studies of deep brain stimulation for Parkinson’s disease: a systematic review of the literature
Gaddum Duemani Reddy
Andres M. Lozano
Review 23 August 2017 Pages: 287 - 295
Lateralisation in Parkinson disease
P. Riederer
K. A. Jellinger
R. Krüger
Review 14 April 2018 Pages: 297 - 312
The enteric nervous system in PD: gateway, bystander victim, or source of solutions
Kathleen Shannon
Pieter Vanden Berghe
Review 14 June 2018 Pages: 313 - 326
The neurobiology of impulse control disorders in Parkinson’s disease: from neurotransmitters to neural networks
Chris Vriend
Review Open access 30 January 2018 Pages: 327 - 336

Volume 373, Issue 1

Special issue “Parkinson’s disease”

Genetic risk factors in Parkinson’s disease

The genetic architecture of mitochondrial dysfunction in Parkinson’s disease

The LRRK2 signalling system

Molecular mechanisms of α-synuclein and GBA1 in Parkinson’s disease

iPS cells in the study of PD molecular pathogenesis

Convergent pathways in Parkinson’s disease

Computational systems biology approaches for Parkinson’s disease

Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease

Neurodegeneration and the ordered assembly of α-synuclein

Is Lewy pathology in the human nervous system chiefly an indicator of neuronal protection or of toxicity?

The concept of alpha-synuclein as a prion-like protein: ten years after

Release and uptake of pathologic alpha-synuclein

In vivo models of alpha-synuclein transmission and propagation

ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences

A critical review of the prion hypothesis of human synucleinopathies

Locus coeruleus

Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies

The REM sleep circuit and how its impairment leads to REM sleep behavior disorder

Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD?

Postmortem studies of deep brain stimulation for Parkinson’s disease: a systematic review of the literature

Lateralisation in Parkinson disease

The enteric nervous system in PD: gateway, bystander victim, or source of solutions

The neurobiology of impulse control disorders in Parkinson’s disease: from neurotransmitters to neural networks

Navigation